Midkine (MK) is the product of a retinoic acid-responsive gene (1) , and in its mature, secreted protein form it has a molecular weight of 13 kDa (2, 3) . MK was discovered in 1988 through the screening of genes differentially expressed during the differentiation of embryonal carcinoma cells (1) . Heparin-binding growth-associated molecule, which has approximately 50% identity with MK, was discovered as a heparinbinding protein isolated from the perinatal rat brain in 1989 (4) . Pleiotrophin (PTN), another name for the same molecule, was discovered and was initially named HBGF-8 as a mitogenic protein with a heparin-binding property isolated from the bovine uterus in 1989 (5) . All 10 cysteines in vertebrate MK and PTN are conserved (68) . MK consists of two main domains, i.e. the N-and C-terminal half domains. Each domain is formed by three anti-parallel b-sheets ( Fig. 1) (9) . PTN has a similar structure (10). In addition, MK and PTN share several common characteristics, such as heparin-binding and neurite outgrowthpromoting activities, and high expression levels in cancers (35, 11, 12) . Thus, the MK family consists of only these two members; this has been confirmed by whole-genome analysis.
There are two possible heparin-binding sites, named clusters I and II, in the C-terminal half domain of MK ( Fig. 1) (68) . Cluster I seems to be particularly important for MK activities, such as neurite outgrowthpromoting and neuronal cell migration-promoting activities (13, 14) . MK is evolutionally conserved in mammals, rodents, fishes and Xenopus. Its C-terminal half is especially conserved, as the N-terminal half of miple in Drosophila (6) .
MK plays critical roles in a variety of biological phenomena. It is mainly involved in (i) cancer, (ii) inflammation/immunity, (iii) blood pressure, (iv) development and (v) tissue protection. Since MK could be an important molecular target for the treatment of various diseases, it is important to elucidate how MK exerts its functions, which is not yet completely understood. In this review, to facilitate investigation into this important molecule, we will briefly overview MKrelated biological phenomena and then focus on the candidate receptors of MK.
Biological Phenomena in Which MK Is Involved
In vivo phenotypes after manipulation of MK are striking. Figure 2 shows the five main areas of MK involvement and related in vitro activities. Among the five areas, blockade or knockdown of MK is expected to be effective for therapies in cancer, inflammation/immunity and blood pressure. In contrast, in tissue protection, MK itself could be beneficial for therapy. An integrative understanding of the biological activities of MK in all these areas may be important to verify the mechanisms of MK action and establish MK-oriented therapies.
in a variety of carcinomas and are a predictive factor for poor prognosis in neuroblastoma, the most common extracranial solid tumour of children (16, 17) . Tumour cells are the main source of MK expression. Knockdown of MK suppresses tumour growth in Xenograft models (18) . Furthermore, the significance of endogenous MK in tumorigenesis has recently been established: MK knockout (KO) mice show lower tumour incidence and slower tumorigenesis in a neuroblastoma model (19) . Interestingly, MK expression in cancer tissues is also associated with chemotherapy resistance (20, 21) . MK knockdown or blockade in combination with an anticancer drug exhibits enhanced tumoricidal effects (22, 23).
Inflammation and immunity MK expression is induced in inflammation, and MK plays an indispensable role in inflammation through its involvement in the recruitment of inflammatory cells. Neointima formation is the basic pathology of vascular stenosis associated with various vascular disorders, such as atherosclerosis and restenosis after angioplasty. Recruitment of inflammatory cells to the vessel wall is a fundamental event and prerequisite to neointima formation. MK expression is observed in proliferating smooth muscle cells in the vessel wall during neointima formation. MK KO mice show strikingly less stenosis in a vascular restenosis model, whereas exogenous MK in the KO mice promotes inflammatory cell recruitment and exacerbates neointima formation, and consequently vascular stenosis (24). MK small interfering RNA (siRNA) externally administered to the vascular wall ameliorates restenosis in a rabbit vein graft model (25).
Renal reperfusion injury induces MK expression in the proximal tubules (26), and antisense oligonucleotides against MK ameliorate this injury (27). MK KO mice show strikingly less damage in cisplatin-induced renal injury and diabetic nephropathy (2830). The association of MK and pathogeneses has also been reported for rheumatoid arthritis and Crohn's disease (31, 32).
MK is also involved in immunologic responses. Experimental autoimmune encephalomyelitis (EAE) is a model of multiple sclerosis, an autoimmune disease affecting the central nervous system. MK exacerbates EAE by decreasing regulatory CD4(þ)CD25(þ) Foxp3(þ) T cells (Tregs), a population that regulates the development of autoimmune responses (33). MK also suppresses the generation of tolerogenic dendritic cells (DCregs), which drive the development of inducible Treg (34). MK suppresses CD45RB expression and promotes IL-12 production by reducing phosphorylated STAT3 levels via SHP2 in DCregs. Thus, MK deficiency or blockade leads to suppression of EAE.
Blood pressure
It has been reported that MK KO mice exhibit an increase in expression of renin, angiotensinogen, angiotensin-converting enzyme and angiotensin II receptors in the aorta (35). PTN KO mice show similar expression patterns except in the case of angiotensinogen, which is expressed at a level equal to that in the wild-type mice (36). These findings suggest that MK and PTN play suppressive roles in the reninangiotensin system. Nevertheless, MK KO mice do not show abnormal blood pressure (37). Furthermore, we found that MK KO mice show normal blood pressure in a chronic kidney disease model, whereas wild-type mice manifest hypertension (37). In this model, 5/6 nephrectomy induces MK expression in the lung, which in turn promotes the expression of angiotensin-converting enzyme and consequently induces hypertension. Therefore, MK could be a factor which governs the inter-organ cross-talk between the kidney and lung (3739). Exogenous MK systemically administered to MK KO mice restores hypertension after 5/6 nephrectomy. 
Development
In line with the fact that MK was initially discovered as the product of a gene transiently expressed during differentiation of embryonal carcinoma cells, MK expression is strictly regulated during development. It is highly expressed in mid-gestation in various areas where the epithelialmesenchymal interactions take place, e.g. the lung, the pancreas, the small intestine and the metanephros of mouse embryos at E11.5-13.5 (1, 20) . Tissue recombination experiments of the epithelial and mesenchymal components reveal that MK expression is regulated by epithelialmesenchymal interactions in tooth germ (21) . The beads releasing MK inhibit cell proliferation in the dental mesenchyme. Simultaneous application of basic fibroblast growth factor reverses this inhibition. MK-neutralizing antibodies inhibit morphogenesis and cell differentiation in cultured tooth germs.
This context may be relevant to the story of Held out wing (HOW). The RNA-binding protein HOW is highly expressed and downregulates its target mRNAs in the mesoderm during early embryogenesis of Drosophila. The mRNA of miple, which is a Drosophila MK and PTN orthologue, is one of the most specifically elevated RNAs in the mesoderm of how germline clone embryos and exhibits specific binding to HOW via its 3 0 -UTR (40). Overexpression of miple leads to abnormal scattered MAPK activation and phenocopies the mesoderm spreading phenotype of how germline clone embryos.
The unique MK gene in mammals has two paralogs in zebrafish-MK-a (mdka) and MK-b (mdkb)-whereas the PTN gene exists as a unique gene (41). mdka is expressed in somites and the central area of the neural tube and affects the morphology of somites and the specification of floorplate cells (42). Thus, the medial floor plate (MFP) is the ventralmost structure in the vertebrate neural tube and exerts important organizer functions for the specification and differentiation of neurons and glia. MFP precursor cells are induced in the tailbud in an Mdka-independent manner. Then, as the embryo extends caudally, Mdka derived from the trunk paraxial mesoderm refines a subset of precursor cells and allocates them into the MFP. On the other hand, mdkb is expressed in the dorsal-most region of the neural tube and promotes the growth of neural crest cells (43). Expression of mdkb is under the negative control of BMP signalling. Interestingly, mouse Mdk and Ptn are expressed in the central area and dorsal-most region, respectively, of the developing neural tube (44). Xenopus MK shows a restricted expression in the neural anlagen (45). If Xenopus MK RNA is injected into dorsal vegetal blastomeres at the eight-cell stage, hypertrophic neural tissue is produced (46). This is in sharp contrast to the situation of zebrafish MK: there is no head phenotype in ectopic mdka expression and there are no head structures in ectopic mdkb expression (41, 43).
Tissue protection MK is also involved in tissue protection, repair and regeneration. Adult photoreceptor regeneration in zebrafish induces both mdka and mdkb in horizontal cells and proliferating Mu¨ller cells and their neurogenic progeny (47). Expression of mammalian MK is also induced in areas surrounding infarct after cardiac infarction (48, 49). Local administration of MK ameliorates myocardial infarction (5052). Cerebral infarction and spinal cord injury also induce MK in astrocytes (53, 54) . Intraventricular administration of MK ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils (55) . Furthermore, intravitreal injection of MK promotes survival of photoreceptors and prevents functional damage following light-induced injury (56, 57) .
Candidate Receptors
It has not been determined whether a single receptor can explain the action of this multifunctional growth factor. Alternatively, complexes of some receptors might be formed depending on the cellular context and might mediate MK signalling (Fig. 3) . Here, we review the candidate receptors.
Anaplastic lymphoma kinase
Anaplastic lymphoma kinase (ALK) is a receptor-type protein tyrosine kinase and has been implicated in tumorigenesis through its fusion to a selective gene in a tissue-specific manner, e.g. its fusion to nucleoplasmin in anaplastic large cell lymphoma (58, 59) and to EML4 in non-small-cell lung tumour (60) . Furthermore, it shows missense mutations, most of which are activated forms, in neuroblastoma and anaplastic thyroid tumours. Because of the marked clinical efficacy of ALK inhibitors, ALK is now a promising target for some tumours (61) . Indeed, crizotinib, an ALK inhibitor, has recently been approved by the Food and Drug Administration for the treatment of lung cancer harbouring ALK rearrangement. The affinity between ALK and PTN (K D 30 pM) or MK (K D 100 pM) is high, and ALK has been proposed as a receptor for MK and PTN (15, 62, 63) .
There is a close association between the expressions of ALK and MK and/or PTN. In the neuroblastoma model MYCN transgenic mice, ALK and MK are coordinately expressed in precancerous lesions at 2 weeks of age (Fig. 4) (19) . ALK, MK and PTN are also strongly expressed in gliomas and other tumours (15) . The expression levels of ALK and MK are correlated with patients' prognosis in some tumours, such as colon and prostate cancers (15) .
Functional relationship of ALK, MK and/or PTN has also been reported. Proliferation of chick sympathetic neurons can be enhanced by MK, ALK and its mutants found in neuroblastoma. This proliferation is suppressed by knockdown of ALK or MK (64) . The effect of ALK knockdown can be rescued by ALK and mutant ALK, but not MK, whereas the effect of MK knockdown can be rescued by MK and ALK mutants. A similar functional relationship of MK and ALK has been shown in cannabinoid-resistant glioma cell lines and cannabinoid-resistant primary gliomas (23). The combination of MK siRNA and cannabinoid can effectively induce cell death, mainly through autophagy. Cannabinoid-sensitive glioma cells become resistant if MK is added. This effect of MK can be attenuated by ALK siRNA but not LDL receptorrelated protein 1 (LRP1) siRNA or protein tyrosine phosphatase z (PTPz) siRNA. Cannabinoid suppresses Akt phosphorylation, which can be restored by MK. These results indicate that both MK and ALK play indispensable roles in the growth of chick sympathetic neurons and drug resistance of gliomas and suggest that MK functions upstream of ALK. However, they do not necessarily indicate that MK and ALK have a direct ligandreceptor relationship.
A problem of the MK and ALK axis is that the phenotypes of KO mice of each gene do not overlap, e.g. phenotypes of hippocampal-dependent functions in infants (Table I) . It has also been reported that although ALK phosphorylation and activation of downstream molecules, such as Erk phosphorylation and Akt phosphorylation, can be observed upon cross-linking the ALK with agonist monoclonal antibodies, PTN cannot activate ALK in the same manner (65). We have not observed a clear increase of ALK phosphorylation upon MK administration to ALK-expressing cells (Kishida et al., unpublished data) . The ALK ligand in The functional relevance of these complex formations remains elusive. Thus, the landscape of the mechanisms of MK action has not been fully drawn, and further investigations will be needed.
Drosophila is jelly belly (jeb) (66) , but a mammalian orthologue has not been identified. In Drosophila, jeb activates ALK, leading to activation of the Ras/MAP kinase cascade to specify a select group of visceral muscle precursors as muscle-patterning pioneers. Jeb/ ALK signalling induces the myoblast fusion gene dumbfounded and org-1, a Drosophila homologue of mammalian TBX1, in these cells. The orthologues of MK and PTN in Drosophila are miple1 and miple2, which do not show homology with jeb (67) .
In summary, although the data so far obtained suggest a link between ALK and MK or PTN, the ligandreceptor relationship remains elusive. Further fundamental data, e.g. ligand-induced intracellular signalling and signalling blockade by neutralizing antibodies against ligands, will be required to address this question.
PTPf and integrins
PTPz (also known as RPTPb/z) is a transmembrane tyrosine phosphatase, the extracellular domain of which carries chondroitin sulphate chains (68) . Alternative splicing produces long and short forms of PTPz and a soluble form, named phosphacan. Growth factors, extracellular matrix molecules and cell adhesion molecules bind to PTPz. Substrate-bound PTN promotes neuronal cell migration, which can be blocked by antibody against PTPz (69). PTPz and DNER, a Notch-related transmembrane protein highly expressed in cerebellar Purkinje cells, form complexes and patchily colocalize in the dendrites of Purkinje cells (70) . Normal DNER is actively endocytosed and inhibits the retinoic-acid-induced neurite outgrowth of Neuro-2A cells, a neuroblastoma cell line. PTN increases the tyrosine phosphorylation level of DNER and suppresses the endocytosis. This in turn reverses the inhibition of DNER, promoting neurite extension.
Scatchard analysis for the binding between MK and PTPz shows low-(3.0 nM) and high-(0.58 nM) affinity binding sites in MK. This binding can be blocked by PTN (14) . Interestingly, the removal of chondroitin sulphate chains from PTPz or a mutation at Arg78 in Cluster I of the C-terminal half of mouse MK leads to loss of the high-affinity binding. The C-terminal half, but not the N-terminal half, of MK shows similar high-and low-affinity binding sites for PTPz. Neuronal migration is suppressed by a mutation at Arg78 or by heparin and chondroitin sulphate E. These results suggest that Arg78 in MK plays an essential role in high-affinity binding to PTPz by interacting with the chondroitin sulphate portion of this receptor. Substrate-coated MK or PTN promotes migration of UMR-106 cells, an osteoblast-like cell line that is inhibited by soluble MK or PTN (71) . This haptotactic migration is inhibited by orthovanadate, an inhibitor of protein-tyrosine phosphatase, heparin, chondroitin sulphate E and removal of chondroitin sulphate. These data support the idea that PTPz is involved in this migration.
The maintenance of peripheral B-cell homeostasis relies on three key pathways: (i) BCR tonic signals (e.g. Iga and Syk), (ii) BAFF (BLyS/TALL-1/ THANK/zTNF4) and (iii) CD74 (invariant chain, Ii) and its ligand, macrophage migration inhibitory factor (MIF). MIF binds to CD74 and leads to c-Met activation, which in turn elevates MK expression in both normal mouse splenic B and chronic lymphocytic leukemia cells (72) . MK promotes survival of B cells but not those lacking PTPz. Thus, the MK/PTPz axis works downstream of MIF/CD74 and is essential for the survival and homeostasis of normal peripheral mature B cells and chronic lymphocytic leukemia cells. PTPz also appears to mediate MK signals that negatively regulate Wnt signalling and thereby suppress osteoblast proliferation (73) .
a4b1-and a6b1-integrin bind MK (74) . Anti-a4 and anti-a5 antibodies inhibit the MK-dependent migration of osteoblastic cells and the MK-dependent neurite outgrowth of embryonic neurons, respectively. PTPz colocalizes with integrins a 6 b 1 and a 4 b 1 , and the resulting complex mediates MK-induced osteoblastic cell migration (74) . In contrast, while integrin a n b 3 directly binds to PTPz, and this complex mediates PTN-induced migration of human endothelial cells, Mechanisms of midkine action MK binds to PTPz but not integrin a n b 3 on these cells (75) . In addition, cross-talk between ALK and PTPz on PTN signalling has been reported. The direct interaction of PTN and ALK does not induce phosphorylation of ALK, but ALK is phosphorylated through the PTN-PTPz signalling pathway (76) . It has not been determined whether a ligand can activate the phosphatase activities of the PTP family members in natural states. Indeed, it has not been proven whether MK or PTN can activate the phosphatase activity of PTPz. But substrates of the PTP family have been discovered. PTPz has multiple substrate proteins, including G-protein-coupled receptor kinase-interactor 1 (Git1), membrane-associated guanylate kinase, WW and PDZ domain-containing 1 (Magi1), GTPase-activating protein for Rho GTPase (p190RhoGAP) and paxillin (77) . 
Notch2
MK activates Notch2 signalling, leading to proteinprotein interactions between Hes1 and Jak2/ Stat3 intermediates in HaCaT keratinocytes, which in turn undergo epithelialmesenchymal transition (EMT) (78) . In this context, it is interesting that chemoresistant pancreatic ductal adenocarcinoma cells highly express Notch2 and undergo EMT. Gemcitabine, the front-line drug used for the treatment of this cancer, induces MK expression. MKNotch2 interaction results in activation of Notch signalling, induction of EMT, upregulation of NF-kB and promotion of chemoresistance. Knockdown of MK leads to sensitization to gemcitabine treatment (79) . MK also appears to activate Notch2 in neuroblastoma in MYCN transgenic mice. We have recently found that MK-deficient MYCN transgenic mice show defects in activation of Notch2. Anti-MK RNA aptamer attenuates Notch2-HES1 signalling and suppresses tumour formation of neuroblastoma (19) . Interestingly, the expressions of MK and ALK and the activation of Notch2 coincide in the precancerous lesion in this model (Fig. 4) . However, whether a ligandreceptor relationship exists between MK and Notch2 has not been conclusively determined.
LRP1
LRP1 belongs to the LDL receptor family. Although the founding member of this family, the LDL receptor, is involved solely in lipoprotein metabolism, LRP1 has a variety of ligands and is involved in many processes, including lipid metabolism, regulation of proteinases and proteinase inhibitors, virus infection, cellular signal transduction and neurotransmission (80) . MK-affinity chromatography of E13 mouse embryos enriched many MK-bound membrane proteins, including LRP1 and integrins. MK binds to LRP1 with high affinity to MK (K D 3.5 nM). Receptor-associated protein, which is a specialized ER chaperon for LRP and interferes with the binding between LRP1 and its ligands, inhibits MK-dependent survival of embryonic neurons (81) . After binding to LRP1, MK is endocytosed and degraded in lysosomes. A portion of the endocytosed MK enters the cytosol from endosomes, binds to nucleolin, a cytoplasm-nucleus shuttle protein, and then enters the nucleus (Fig. 3 ). This nuclear targeting by MK plays at least some role in MKmediated cell survival. MK in the cytosol and nucleus undergoes proteosomal degradation (82, 83) . MK also partially protects mouse embryonic stem cells from hypoxic injury through activation of Akt, HO-1 and hypoxia-inducible factor 1 alpha via LRP-1 (84) .
Chemical cross-linking of 125 I-labeled MK and cell surface proteins in a variety of cells shows only a single band in autoradiography, which is the MK-LRP1 cross-linked band (85) . In addition, LRP1-deficient cells do not endocytose MK, and the forced expression of LRP1 in these cells restores MK endocytosis (82) . These data certainly support the idea that LRP1 is the binding partner of MK on the cell surface. However, even if endocytosed MK plays a role in cell survival, LRP1 alone cannot explain all the activities of MK across a wide range of biological phenomena.
Proteoglycans MK bound to heparin-Sepharose cannot be eluted with 0.5 M NaCl, indicating a high affinity between MK and heparin. Indeed, haemodialysis with heparin rapidly increases serum MK levels in patients with chronic kidney disease (86) . Heparin administration to healthy volunteers also increases MK levels. These data suggest that MK is reserved in the vascular bed and released by heparin and support the idea that the binding of MK and heparin or heparin sulphate has biological significance. MK indeed binds to heparan sulphate proteoglycans, such as syndecan-1, -2 and -3 (8789).
Because chondroitin sulphate, particularly the chondroitin sulphate-E unit, also shows a high affinity for MK, membrane-anchored chondroitin sulphate proteoglycans could be a receptor or reservoir for MK (14, 71). As described above, PTPz is a transmembrane chondroitin sulphate proteoglycan.
Perspectives
Both MK KO and PTN KO mice develop normally. However, double KO for MK and PTN results in a partial loss during the embryonic period, growth retardation after birth and female infertility (90) . This suggests that the MK family is indispensable for development and that MK and PTN are functionally redundant. On the other hand, MK KO and PTN KO mice show different phenotypes in some respects, e.g. in terms of their responses to amphetamine and their bone formation (Table I ) (9193). Therefore, it is necessary to determine whether MK and PTN share a common receptor.
Considering the inconsistency of phenotypes of KO mice for MK and its candidate receptors (Table I) , a one-to-one partnership between MK and these receptors cannot be expected. Complex formation between receptors, e.g. PTPz and integrins (74) , or cross-talks between receptors, e.g. PTPz and ALK (76) , might occur depending on the cellular context and might mediate MK signalling. This idea has not been proven yet, but merits future investigation. On the other hand, there is still a possibility that a novel single receptor could explain the actions of this multifunctional growth factor. The continued accumulation and study of data on the function of MK and its interacting proteins will facilitate understanding of the mechanism of MK actions and the development of therapies targeting this intriguing growth factor. 
